Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Pain Management Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Generic Opioid
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drugs for Pain Management Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Pain Management Market Perspective (2018-2034)
2.2 Drugs for Pain Management Growth Trends by Region
2.2.1 Global Drugs for Pain Management Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Drugs for Pain Management Historic Market Size by Region (2018-2023)
2.2.3 Drugs for Pain Management Forecasted Market Size by Region (2024-2034)
2.3 Drugs for Pain Management Market Dynamics
2.3.1 Drugs for Pain Management Industry Trends
2.3.2 Drugs for Pain Management Market Drivers
2.3.3 Drugs for Pain Management Market Challenges
2.3.4 Drugs for Pain Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Pain Management Players by Revenue
3.1.1 Global Top Drugs for Pain Management Players by Revenue (2018-2023)
3.1.2 Global Drugs for Pain Management Revenue Market Share by Players (2018-2023)
3.2 Global Drugs for Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Pain Management Revenue
3.4 Global Drugs for Pain Management Market Concentration Ratio
3.4.1 Global Drugs for Pain Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Pain Management Revenue in 2024
3.5 Drugs for Pain Management Key Players Head office and Area Served
3.6 Key Players Drugs for Pain Management Product Solution and Service
3.7 Date of Enter into Drugs for Pain Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Pain Management Breakdown Data by Type
4.1 Global Drugs for Pain Management Historic Market Size by Type (2018-2023)
4.2 Global Drugs for Pain Management Forecasted Market Size by Type (2024-2034)
5 Drugs for Pain Management Breakdown Data by Application
5.1 Global Drugs for Pain Management Historic Market Size by Application (2018-2023)
5.2 Global Drugs for Pain Management Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Drugs for Pain Management Market Size (2018-2034)
6.2 North America Drugs for Pain Management Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Drugs for Pain Management Market Size by Country (2018-2023)
6.4 North America Drugs for Pain Management Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Pain Management Market Size (2018-2034)
7.2 Europe Drugs for Pain Management Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Drugs for Pain Management Market Size by Country (2018-2023)
7.4 Europe Drugs for Pain Management Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Pain Management Market Size (2018-2034)
8.2 Asia-Pacific Drugs for Pain Management Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Drugs for Pain Management Market Size by Region (2018-2023)
8.4 Asia-Pacific Drugs for Pain Management Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Pain Management Market Size (2018-2034)
9.2 Latin America Drugs for Pain Management Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Drugs for Pain Management Market Size by Country (2018-2023)
9.4 Latin America Drugs for Pain Management Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Pain Management Market Size (2018-2034)
10.2 Middle East & Africa Drugs for Pain Management Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Drugs for Pain Management Market Size by Country (2018-2023)
10.4 Middle East & Africa Drugs for Pain Management Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Drugs for Pain Management Introduction
11.1.4 GSK Revenue in Drugs for Pain Management Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Pain Management Introduction
11.2.4 Pfizer Revenue in Drugs for Pain Management Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Detail
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Drugs for Pain Management Introduction
11.3.4 Grunenthal Revenue in Drugs for Pain Management Business (2018-2023)
11.3.5 Grunenthal Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Drugs for Pain Management Introduction
11.4.4 Sanofi Revenue in Drugs for Pain Management Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Drugs for Pain Management Introduction
11.5.4 Bayer Revenue in Drugs for Pain Management Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Drugs for Pain Management Introduction
11.6.4 AstraZeneca Revenue in Drugs for Pain Management Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Detail
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Drugs for Pain Management Introduction
11.7.4 Eli Lilly Revenue in Drugs for Pain Management Business (2018-2023)
11.7.5 Eli Lilly Recent Development
11.8 Endo
11.8.1 Endo Company Detail
11.8.2 Endo Business Overview
11.8.3 Endo Drugs for Pain Management Introduction
11.8.4 Endo Revenue in Drugs for Pain Management Business (2018-2023)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Drugs for Pain Management Introduction
11.9.4 Merck Revenue in Drugs for Pain Management Business (2018-2023)
11.9.5 Merck Recent Development
11.10 Yunnan Baiyao
11.10.1 Yunnan Baiyao Company Detail
11.10.2 Yunnan Baiyao Business Overview
11.10.3 Yunnan Baiyao Drugs for Pain Management Introduction
11.10.4 Yunnan Baiyao Revenue in Drugs for Pain Management Business (2018-2023)
11.10.5 Yunnan Baiyao Recent Development
11.11 Teikoku Seiyaku
11.11.1 Teikoku Seiyaku Company Detail
11.11.2 Teikoku Seiyaku Business Overview
11.11.3 Teikoku Seiyaku Drugs for Pain Management Introduction
11.11.4 Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2018-2023)
11.11.5 Teikoku Seiyaku Recent Development
11.12 Teva
11.12.1 Teva Company Detail
11.12.2 Teva Business Overview
11.12.3 Teva Drugs for Pain Management Introduction
11.12.4 Teva Revenue in Drugs for Pain Management Business (2018-2023)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Detail
11.13.2 J&J Business Overview
11.13.3 J&J Drugs for Pain Management Introduction
11.13.4 J&J Revenue in Drugs for Pain Management Business (2018-2023)
11.13.5 J&J Recent Development
11.14 Assertio Therapeutics
11.14.1 Assertio Therapeutics Company Detail
11.14.2 Assertio Therapeutics Business Overview
11.14.3 Assertio Therapeutics Drugs for Pain Management Introduction
11.14.4 Assertio Therapeutics Revenue in Drugs for Pain Management Business (2018-2023)
11.14.5 Assertio Therapeutics Recent Development
11.15 Allergan
11.15.1 Allergan Company Detail
11.15.2 Allergan Business Overview
11.15.3 Allergan Drugs for Pain Management Introduction
11.15.4 Allergan Revenue in Drugs for Pain Management Business (2018-2023)
11.15.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs for Pain Management Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Generic Opioid
Table 3. Key Players of Branded Opioids
Table 4. Key Players of NSAIDs
Table 5. Key Players of Others
Table 6. Global Drugs for Pain Management Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Drugs for Pain Management Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Drugs for Pain Management Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Drugs for Pain Management Market Share by Region (2018-2023)
Table 10. Global Drugs for Pain Management Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Drugs for Pain Management Market Share by Region (2024-2034)
Table 12. Drugs for Pain Management Market Trends
Table 13. Drugs for Pain Management Market Drivers
Table 14. Drugs for Pain Management Market Challenges
Table 15. Drugs for Pain Management Market Restraints
Table 16. Global Drugs for Pain Management Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Drugs for Pain Management Market Share by Players (2018-2023)
Table 18. Global Top Drugs for Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2024)
Table 19. Ranking of Global Top Drugs for Pain Management Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Drugs for Pain Management Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drugs for Pain Management Product Solution and Service
Table 23. Date of Enter into Drugs for Pain Management Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for Pain Management Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Drugs for Pain Management Revenue Market Share by Type (2018-2023)
Table 27. Global Drugs for Pain Management Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Drugs for Pain Management Revenue Market Share by Type (2024-2034)
Table 29. Global Drugs for Pain Management Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Drugs for Pain Management Revenue Market Share by Application (2018-2023)
Table 31. Global Drugs for Pain Management Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Drugs for Pain Management Revenue Market Share by Application (2024-2034)
Table 33. North America Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Drugs for Pain Management Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Drugs for Pain Management Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Drugs for Pain Management Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Drugs for Pain Management Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Drugs for Pain Management Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Drugs for Pain Management Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Drugs for Pain Management Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Drugs for Pain Management Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Drugs for Pain Management Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Drugs for Pain Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Drugs for Pain Management Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Drugs for Pain Management Market Size by Country (2024-2034) & (US$ Million)
Table 48. GSK Company Detail
Table 49. GSK Business Overview
Table 50. GSK Drugs for Pain Management Product
Table 51. GSK Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 52. GSK Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Drugs for Pain Management Product
Table 56. Pfizer Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Grunenthal Company Detail
Table 59. Grunenthal Business Overview
Table 60. Grunenthal Drugs for Pain Management Product
Table 61. Grunenthal Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 62. Grunenthal Recent Development
Table 63. Sanofi Company Detail
Table 64. Sanofi Business Overview
Table 65. Sanofi Drugs for Pain Management Product
Table 66. Sanofi Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 67. Sanofi Recent Development
Table 68. Bayer Company Detail
Table 69. Bayer Business Overview
Table 70. Bayer Drugs for Pain Management Product
Table 71. Bayer Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. AstraZeneca Company Detail
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Drugs for Pain Management Product
Table 76. AstraZeneca Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Eli Lilly Company Detail
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Drugs for Pain Management Product
Table 81. Eli Lilly Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 82. Eli Lilly Recent Development
Table 83. Endo Company Detail
Table 84. Endo Business Overview
Table 85. Endo Drugs for Pain Management Product
Table 86. Endo Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 87. Endo Recent Development
Table 88. Merck Company Detail
Table 89. Merck Business Overview
Table 90. Merck Drugs for Pain Management Product
Table 91. Merck Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 92. Merck Recent Development
Table 93. Yunnan Baiyao Company Detail
Table 94. Yunnan Baiyao Business Overview
Table 95. Yunnan Baiyao Drugs for Pain Management Product
Table 96. Yunnan Baiyao Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 97. Yunnan Baiyao Recent Development
Table 98. Teikoku Seiyaku Company Detail
Table 99. Teikoku Seiyaku Business Overview
Table 100. Teikoku Seiyaku Drugs for Pain Management Product
Table 101. Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 102. Teikoku Seiyaku Recent Development
Table 103. Teva Company Detail
Table 104. Teva Business Overview
Table 105. Teva Drugs for Pain Management Product
Table 106. Teva Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 107. Teva Recent Development
Table 108. J&J Company Detail
Table 109. J&J Business Overview
Table 110. J&J Drugs for Pain Management Product
Table 111. J&J Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 112. J&J Recent Development
Table 113. Assertio Therapeutics Company Detail
Table 114. Assertio Therapeutics Business Overview
Table 115. Assertio Therapeutics Drugs for Pain Management Product
Table 116. Assertio Therapeutics Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 117. Assertio Therapeutics Recent Development
Table 118. Allergan Company Detail
Table 119. Allergan Business Overview
Table 120. Allergan Drugs for Pain Management Product
Table 121. Allergan Revenue in Drugs for Pain Management Business (2018-2023) & (US$ Million)
Table 122. Allergan Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Pain Management Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Drugs for Pain Management Market Share by Type: 2024 VS 2034
Figure 3. Generic Opioid Features
Figure 4. Branded Opioids Features
Figure 5. NSAIDs Features
Figure 6. Others Features
Figure 7. Global Drugs for Pain Management Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global Drugs for Pain Management Market Share by Application: 2024 VS 2034
Figure 9. Hospitals Case Studies
Figure 10. Drugstores Case Studies
Figure 11. Others Case Studies
Figure 12. Drugs for Pain Management Report Years Considered
Figure 13. Global Drugs for Pain Management Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Drugs for Pain Management Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Drugs for Pain Management Market Share by Region: 2024 VS 2034
Figure 16. Global Drugs for Pain Management Market Share by Players in 2024
Figure 17. Global Top Drugs for Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Pain Management as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Drugs for Pain Management Revenue in 2024
Figure 19. North America Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Drugs for Pain Management Market Share by Country (2018-2034)
Figure 21. United States Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Drugs for Pain Management Market Share by Country (2018-2034)
Figure 25. Germany Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Drugs for Pain Management Market Share by Region (2018-2034)
Figure 33. China Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Drugs for Pain Management Market Share by Country (2018-2034)
Figure 41. Mexico Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Drugs for Pain Management Market Share by Country (2018-2034)
Figure 45. Turkey Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Drugs for Pain Management Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 49. Grunenthal Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 50. Sanofi Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 53. Eli Lilly Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 54. Endo Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 56. Yunnan Baiyao Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 57. Teikoku Seiyaku Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 58. Teva Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 59. J&J Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 60. Assertio Therapeutics Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 61. Allergan Revenue Growth Rate in Drugs for Pain Management Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed